Terms: = Kidney tumors AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
171 results:
1. An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.
Chen B; Zhou M; Guo L; Huang H; Sun X; Peng Z; Wu D; Chen W
Front Biosci (Landmark Ed); 2024 Mar; 29(3):121. PubMed ID: 38538287
[TBL] [Abstract] [Full Text] [Related]
2. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mtor signaling pathway.
Huang B; Ren J; Ma Q; Yang F; Pan X; Zhang Y; Liu Y; Wang C; Zhang D; Wei L; Ran L; Zhao H; Liang C; Wang X; Wang S; Li H; Ning H; Ran A; Li W; Wang Y; Xiao B
Mol Cancer; 2024 Feb; 23(1):34. PubMed ID: 38360682
[TBL] [Abstract] [Full Text] [Related]
3. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mtor inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
4. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mtor Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.
Wang X; Yao L; Li Z; Zhang J; Ruan M; Mulati Y; Gan Y; Zhang Q
Int J Biol Sci; 2024; 20(2):643-663. PubMed ID: 38169650
[No Abstract] [Full Text] [Related]
5. Molecular Expression and Prognostic Implications of Krüppel-Like Factor 3 (KLF3) in Clear Cell Renal Cell Carcinoma.
Wan B; Zhang W; Deng X; Lu Y; Zhang Z; Yang Y
Crit Rev Eukaryot Gene Expr; 2024; 34(2):45-59. PubMed ID: 38073441
[TBL] [Abstract] [Full Text] [Related]
6. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification.
Wang H; Ma X; Li S; Ni X
Aging (Albany NY); 2023 Nov; 15(22):13150-13162. PubMed ID: 37993256
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma.
Pezzicoli G; Ciciriello F; Musci V; Salonne F; Ragno A; Rizzo M
Curr Oncol; 2023 Oct; 30(10):9276-9290. PubMed ID: 37887570
[TBL] [Abstract] [Full Text] [Related]
8. PLCL1 suppresses tumour progression by regulating AMPK/mtor-mediated autophagy in renal cell carcinoma.
Pan Z; Huang J; Song H; Xiao Y; Liu T; Zeng Y; Zhu H; Yang K
Aging (Albany NY); 2023 Oct; 15(19):10407-10427. PubMed ID: 37801481
[TBL] [Abstract] [Full Text] [Related]
9. The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma.
Yang Y; Liang J; Zhao J; Wang X; Feng D; Xu H; Shen Y; Zhang Y; Dai J; Wang Z; Wei Q; Liu Z
Diagn Pathol; 2023 Aug; 18(1):96. PubMed ID: 37608295
[TBL] [Abstract] [Full Text] [Related]
10. Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study.
Fázio MR; Cristelli MP; Tomimori J; Koga CE; Ogawa MM; Beneventi GT; Tedesco-Silva H; Medina-Pestana J
J Bras Nefrol; 2023; 45(4):480-487. PubMed ID: 37565728
[TBL] [Abstract] [Full Text] [Related]
11. FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mtor signaling pathway.
Lv Z; Wang M; Hou H; Tang G; Xu H; Wang X; Li Y; Wang J; Liu M
Int J Biol Sci; 2023; 19(11):3293-3306. PubMed ID: 37496990
[No Abstract] [Full Text] [Related]
12. Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor.
Zhang H; Bai L; Wu XQ; Tian X; Feng J; Wu X; Shi GH; Pei X; Lyu J; Yang G; Liu Y; Xu W; Anwaier A; Zhu Y; Cao DL; Xu F; Wang Y; Gan HL; Sun MH; Zhao JY; Qu Y; Ye D; Ding C
Nat Commun; 2023 Jul; 14(1):4274. PubMed ID: 37460463
[TBL] [Abstract] [Full Text] [Related]
13. Loss of MIR503HG facilitates papillary renal cell carcinoma associated lymphatic metastasis by triggering NOTCH1/VEGFC signaling.
Wang Y; Zheng X; Huang W; Lu J; Hou N; Qi J; Ma J; Xue W; Zheng J; Zhai W
Int J Biol Sci; 2023; 19(10):3266-3284. PubMed ID: 37416763
[TBL] [Abstract] [Full Text] [Related]
14. Risk signature identification and NPRL2 affects sunitinib sensitivity in clear cell renal cell carcinoma.
Du X; Zhao Z; Zhao X; Wang H; Jiang L; Tang W
Biochem Biophys Res Commun; 2023 Jun; 663():122-131. PubMed ID: 37121122
[TBL] [Abstract] [Full Text] [Related]
15. Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
Wang Y; Tian X; Zhu SX; Xu WH; Anwaier A; Su JQ; Gan HL; Qu YY; Zhao JY; Zhang HL; Ye DW
World J Surg Oncol; 2023 Mar; 21(1):98. PubMed ID: 36927438
[TBL] [Abstract] [Full Text] [Related]
16. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract] [Full Text] [Related]
17. Antitumor Effects of Ononin by Modulation of Apoptosis in Non-Small-Cell Lung Cancer through Inhibiting PI3K/Akt/mtor Pathway.
Gong G; Ganesan K; Xiong Q; Zheng Y
Oxid Med Cell Longev; 2022; 2022():5122448. PubMed ID: 36605098
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
[TBL] [Abstract] [Full Text] [Related]
19. LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mtor Signaling Pathway.
Zhang X; Wu H; Yan X; Ma J; Chen Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429034
[TBL] [Abstract] [Full Text] [Related]
20. Downregulation of FXYD2 Is Associated with Poor prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma.
Zhang Z; Tang Y; Li L; Yang W; Xu Y; Zhou J; Ma K; Zhang K; Zhuang H; Gong Y; Gong K
J Immunol Res; 2022; 2022():4946197. PubMed ID: 36313180
[TBL] [Abstract] [Full Text] [Related]
[Next]
